These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 16386599)
1. Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation. Aguilera I; Sousa JM; Gavilan F; Bernardos A; Wichmann I; Nuñez-Roldan A Transplant Proc; 2005 Nov; 37(9):3968-9. PubMed ID: 16386599 [TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Aguilera I; Sousa JM; Gavilán F; Bernardos A; Wichmann I; Nuñez-Roldán A Liver Transpl; 2004 Sep; 10(9):1166-72. PubMed ID: 15350010 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation. Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747 [TBL] [Abstract][Full Text] [Related]
4. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation. Rodriguez-Mahou M; Salcedo M; Fernandez-Cruz E; Tiscar JL; Bañares R; Clemente G; Vicario JL; Alvarez E; Rodriguez-Sainz C Transplantation; 2007 Apr; 83(8):1126-9. PubMed ID: 17452905 [TBL] [Abstract][Full Text] [Related]
5. Alloimmune response against donor glutathione S-transferase T1 antigen in renal transplant recipients. Aguilera I; Wichmann I; Gentil MA; Gonzalez-Escribano F; Nuñez-Roldan A Am J Kidney Dis; 2005 Aug; 46(2):345-50. PubMed ID: 16112055 [TBL] [Abstract][Full Text] [Related]
6. Antibodies against the donor antigen glutathione S-transferase T1 after renal transplantation. Aguilera I; Wichmann I; Gentil MA; Gonzalez-Escribano F; Nuñez-Roldan A Transplant Proc; 2005 Apr; 37(3):1457-8. PubMed ID: 15866637 [TBL] [Abstract][Full Text] [Related]
7. Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation. Aguilera I; Sousa JM; Praena JM; Gómez-Bravo MA; Núñez-Roldan A Clin Transplant; 2011; 25(2):207-12. PubMed ID: 20236132 [TBL] [Abstract][Full Text] [Related]